发明公开
- 专利标题： TRANSMUCOSAL DELIVERY SYSTEM FOR MEDICINAL ACTIVE INGREDIENT TO SUBMUCOSA OF BLADDER
-
申请号： EP20871804.9申请日： 2020-10-02
-
公开(公告)号： EP4039279A1公开(公告)日： 2022-08-10
- 发明人: NARITA, Muneto , ISHII, Kensuke , SHIMURA, Akihito
- 申请人： Seikagaku Corporation
- 申请人地址： JP Tokyo 100-0005 6-1, Marunouchi 1-chome Chiyoda-ku
- 代理机构： Hoffmann Eitle
- 优先权： JP2019183082 20191003
- 国际公布： WO2021066175 20210408
- 主分类号： A61K47/61
- IPC分类号： A61K47/61 ; A61P13/10 ; A61P43/00 ; A61K45/00 ; G01N33/15 ; G01N33/50 ; A61K31/192 ; A61K31/196 ; A61K31/495 ; A61K31/575 ; A61K31/58
摘要：
As a system that enables effective delivery of a pharmaceutical active ingredient to a submucosal tissue of the bladder, a transmucosal delivery system including a conjugate of a hydrophobic compound containing the pharmaceutical active ingredient and chondroitin sulfate is provided.
信息查询
IPC分类:
